Top Markets
Coin of the day
Healios K.K. Healios K.K.

Healios K.K.

4593
शेयरों में रैंक #17173
Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011,... Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011, specializes in the discovery, development, manufacturing, and commercialization of advanced cell and regenerative medical therapies. The company operates across key markets including Japan, Europe, and the United States. Its robust pipeline features several cellular and tissue-based products, such as HLCR011 and HLCR012, which are induced pluripotent stem cell (iPSC)-derived regenerative medicines aimed at treating age-related macular degeneration. Another iPSC-based therapy, HLCL041, is being developed for metabolic liver disease. Furthermore, Healios is progressing HLCM051, a regenerative treatment designed for ischemic stroke and acute respiratory distress syndrome, alongside HLCN061 for solid tumor indications. The company also maintains a joint research partnership with Hyogo Medical University, focusing on eNK cell-based cancer immunotherapies to combat mesothelioma. Healios K.K. adopted its current name in September 2013, having previously operated under the name Retina Institute Japan, K.K.
शेयर मूल्य
$1.89
मार्केट कैप
$254.55M
बदलाव (1 दिन)
-2.03%
बदलाव (1 वर्ष)
-48.53%
देश
JP
व्यापार Healios K.K. (4593)

श्रेणी

Healios K.K. (4593) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $1.91 (2026-09-01 को)

दिन का सबसे निम्न समापन मूल्य: $12.24 (2015-06-01 को)
Healios K.K. के स्टॉक मूल्य का इतिहास 2015 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 10.25%
2025 88.62%
2024 -2.29%
2023 -42.34%
2022 -81.62%
2021 -40.66%
2020 45.21%
2019 -16.02%
2018 2.08%
2017 -12.10%
2016 85.34%
2015 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$550.65 37.32%
US
$1.05K 48.27%
NL
$148.50 513.89%
US
$122.21 -10.03%
AU
$763.69 9.05%
CH